The Challenge

• Africa produces less than 1% of the world’s total vaccine supply1.
• African countries are vulnerable to vaccine shortages and global supply 
  chain disruptions.
• Research institutions in southern Africa hold a large portfolio of plant-based vaccine patents, but are struggling to bridge the gap to clinical trials and large-scale vaccine manufacture.
• Plant-based vaccines offer an agile, low-cost technology that could boost 
  local manufacturing and strengthen existing healthcare systems and future pandemic preparedness.
  
  Please download the STEM Impact Memo below to find out more

Launch Event

The memo was launched officially at an event at the 12th African Congress of Immunology,  December 2024.